Clincosm LogoSign in Get a demo

Pharmacist Follow-up, a Qualitative Study of Patient Experience

Sponsor
Hospital Pharmacy of North Norway Trust (Other)
Overall Status
Completed
CT.gov ID
NCT01131715
Collaborator
University of Tromso (Other)
4
Enrollment
1
Location
28.9
Actual Duration (Months)
0.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

A pharmacist follow-up procedure is under development. Patients with coronary heart disease (CHD) is being followed up by a pharmacist for one year with three meetings; at discharge from hospital, after three months and after one year. The evaluation is basically based on quantitative measures as achievement of therapeutic goals, number of drug related problems detected, hospitalisations etc. However, the patients' own experience with the follow-up procedure cannot be evaluated using these measures. Thus, a qualitative approach is needed. In this study, a total of four patients participating in the follow-up will be included and interviewed. A semistructured interview guide will be used. Interviews will be taped, transcribed and analyzed with the intention to explore how patients experience the follow-up from the pharmacist. A thoruough content analysis will be performed. Patients included must have met the pharmacist at least twice. The pharmacist in charge of the follow-up will recruit patients and hand out study information. Patients will reply to the principal investigator of the study and thus kept anonymous for the pharmacist in charge of the follow-up. No pressure will be put on the patients to join, but it will be emphasized that it will help evaluating the procedure.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    See full publication on http://www.biomedcentral.com/1756-0500/7/197 Garcia et al. BMC Research Notes 2014, 7:197

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    4 participants
    Observational Model:
    Other
    Time Perspective:
    Other
    Official Title:
    Pharmacist Follow-up of Patients With Coronary Heart Disease. A Qualitative Study of Patient Experience.
    Actual Study Start Date :
    Feb 1, 2010
    Actual Primary Completion Date :
    Mar 1, 2010
    Actual Study Completion Date :
    Jul 1, 2012

    Arms and Interventions

    Arm Intervention/Treatment
    Study group

    Patients who are included in the pharmacist follow-up procedure

    Outcome Measures

    Primary Outcome Measures

    1. Qualitative evaluation of the impact of pharmacist follow-up via interviews with the participating patients [3 months or 1 year]

      In the pharmacist follow-up procedure under development, patients have individual "consultations" with a pharmacist three times. Patients are recruited to this study at the second or third consultation. Interviews will be performed with patients included to explore how patients' experience this follow-up procedure. Outcome measures from patient interviews can be counted. In qualitative research, the content of the interviews are thoroughly analysed with focus on the meaning of the informant's/interviewee's sayings. Outcomes will be presented as overall themes touched by the informants.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • must have met the pharmacist at least twice

    • living within the area of Tromsoe city so that interviews are possible

    Exclusion Criteria

    • none as patients are already enrolled in another study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Tromsoe Tromso Norway 9037

    Sponsors and Collaborators

    • Hospital Pharmacy of North Norway Trust
    • University of Tromso

    Investigators

    • Principal Investigator: Lars Smaabrekke, PhD, University of Tromso
    • Study Chair: Beate H Garcia, PhD, Hospital Pharmacy of North Norway Trust

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Beate Hennie Garcia, PhD, Associate Professor, Hospital Pharmacy of North Norway Trust
    ClinicalTrials.gov Identifier:
    NCT01131715
    Other Study ID Numbers:
    • SHAN-002
    First Posted:
    May 27, 2010
    Last Update Posted:
    Jun 29, 2020
    Last Verified:
    Jun 1, 2020
    Keywords provided by Beate Hennie Garcia, PhD, Associate Professor, Hospital Pharmacy of North Norway Trust
    Qualitetive interview
    Coronary heart disease (CHD)
    Patient experience
    Patient perception
    Additional relevant MeSH terms:
    Heart Diseases
    Coronary Disease

    Study Results

    No Results Posted as of Jun 29, 2020